Melissa Yiannoutsos
Board of Directors
Cancer
Avaliaimmuno Therapies
New Zealand
Biography
Melissa Yiannoutsos has spent over 15 years commercialising science for industrial, medical and biotechnology applications in New Zealand in both the private and public sector. She has extensive experience developing and implementing strategies for technology-led organisations and international negotiations. Prior to setting up commercialisation consultancy company, Kerasi Limited in 2008, which was sold to Powerhouse Ventures in 2014, Melissa managed commercialisation and investment portfolios at one of New Zealand’s Crown Research Agencies. During 2000-2003 she was responsible for establishing New Zealand’s first angel investment network, which attracted over $14 million in start up capital for New Zealand technology companies.
Research Interest
Cancer
